{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T04:55:38Z","timestamp":1768452938220,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"30","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.vaccine.2015.05.037","type":"journal-article","created":{"date-parts":[[2015,5,30]],"date-time":"2015-05-30T14:16:12Z","timestamp":1432995372000},"page":"3600-3604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis"],"prefix":"10.1016","volume":"33","author":[{"given":"Maria","family":"Paulke-Korinek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Kundi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ines","family":"Zwazl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Seidl-Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.05.037_bib0145","series-title":"Vaccines","first-page":"312","article-title":"Japanese encephalitis","author":"Halstead","year":"2013"},{"key":"10.1016\/j.vaccine.2015.05.037_bib0150","unstructured":"World Health Organization. International travel and health. Japanese encephalitis, \u3008http:\/\/www.Who.Int\/ith\/en\u3009; [accessed 23.01.15]."},{"key":"10.1016\/j.vaccine.2015.05.037_bib0155","unstructured":"World tourism organization UNWTO. Annual report 2013. \u3008http:\/\/www2.unwto.org\/publication\/unwto-annual-report-2013\u3009; [accessed 21.01.15]."},{"key":"10.1016\/j.vaccine.2015.05.037_bib0160","volume":"81","year":"2006","journal-title":"WER"},{"issue":"10","key":"10.1016\/j.vaccine.2015.05.037_bib0165","doi-asserted-by":"crossref","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2015.05.037_bib0170","doi-asserted-by":"crossref","first-page":"930","DOI":"10.4269\/ajtmh.2010.09-0676","article-title":"Japanese encephalitis in travelers from non-endemic countries, 1973\u20132008","volume":"82","author":"Hills","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.037_bib0175","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1708-8305.2011.00582.x","article-title":"A case of Japanese encephalitis virus infection acquired during a trip in Thailand","volume":"19","author":"Langevin","year":"2012","journal-title":"J Travel Med"},{"issue":"35","key":"10.1016\/j.vaccine.2015.05.037_bib0180","doi-asserted-by":"crossref","first-page":"20573","DOI":"10.2807\/1560-7917.ES2013.18.35.20573","article-title":"A case of Japanese encephalitis in a 20 year-old Spanish sportsman, February 2013","volume":"18","author":"Doti","year":"2013","journal-title":"Eurosurveillance"},{"issue":"7","key":"10.1016\/j.vaccine.2015.05.037_bib0185","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1517\/14712590903042282","article-title":"IC51 Japanese encephalitis vaccine","volume":"9","author":"Kollaritsch","year":"2009","journal-title":"Expert Opin Biol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2015.05.037_bib0190","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1586\/14760584.2013.835638","article-title":"IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis","volume":"12","author":"Jelinek","year":"2013","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2015.05.037_bib0195","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.vaccine.2014.11.046","article-title":"Adverse events following vaccination with an inactivated, Vero cell culture-derived Japanese encephalitis vaccine in the United States, 2009\u20132012","volume":"33","author":"Rabe","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.05.037_bib0200","unstructured":"EPAR summary for the public. Ixiaro 2013, \u3008http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/medicines\/human\/medicines\/000963\/human_med_000862.jsp&mid=WC0b01ac058001d124\u3009; [accessed 12.02.15]."},{"key":"10.1016\/j.vaccine.2015.05.037_bib0205","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.vaccine.2011.01.058","article-title":"Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO\u00ae, IC51","volume":"29","author":"Eder","year":"2011","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2015.05.037_bib0210","doi-asserted-by":"crossref","first-page":"5197","DOI":"10.1016\/j.vaccine.2010.05.069","article-title":"Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO, IC51","volume":"28","author":"Dubischar-Kastner","year":"2010","journal-title":"Vaccine"},{"issue":"25","key":"10.1016\/j.vaccine.2015.05.037_bib0215","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.vaccine.2005.01.085","article-title":"Insufficient protection for healthy elderly adults by tetanus and TBE vaccines","volume":"23","author":"Hainz","year":"2005","journal-title":"Vaccine"},{"issue":"S5","key":"10.1016\/j.vaccine.2015.05.037_bib0220","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1469-0691.2012.03944.x","article-title":"Vaccines for the elderly","volume":"18","author":"Weinberger","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2015.05.037_bib0225","unstructured":"Wagner A, Garner-Spitzer E, Jasinska J, Paulke-Korinek M, Hofer M, Kollaritsch H, et al. Characterisation of immune responses to primary Japanese encephalitis vaccination in elderly compared to young vaccinees. Poster at CISTM 2013 in Maastricht, PO 21.02."},{"key":"10.1016\/j.vaccine.2015.05.037_bib0230","doi-asserted-by":"crossref","unstructured":"Dubischar-Kastner K, Cramer JP, Eder S, Jelinek T, Jilma B, Kollaritsch H, et al. Immunogenicity and safety of the inactivated Japanese encephalitis vaccine IXIARO\u00ae, IC51, in Elderly. Poster at CISTM 2013 in Maastricht, PO14.04.","DOI":"10.1016\/j.ijid.2010.02.615"},{"issue":"19","key":"10.1016\/j.vaccine.2015.05.037_bib0235","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1128\/JVI.00080-06","article-title":"Cryptic properties of a cluster of dominant flavivirus cross-reactive antigenic sites","volume":"80","author":"Stiasny","year":"2006","journal-title":"J Virol"},{"issue":"24","key":"10.1016\/j.vaccine.2015.05.037_bib0240","doi-asserted-by":"crossref","first-page":"13975","DOI":"10.1128\/JVI.78.24.13975-13986.2004","article-title":"Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes","volume":"78","author":"Crill","year":"2004","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2015.05.037_bib0245","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/infdis\/jir122","article-title":"A tick-borne encephalitis vaccine based on the European prototype strain induces broadly reactive cross-neutralizing antibodies in humans","volume":"203","author":"Orlinger","year":"2011","journal-title":"J Infect Dis"},{"issue":"Pt 12","key":"10.1016\/j.vaccine.2015.05.037_bib0250","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1099\/vir.0.031641-0","article-title":"Flavivirus induced antibody cross-reactivity","volume":"92","author":"Mansfield","year":"2011","journal-title":"J Gen Virol"},{"issue":"48","key":"10.1016\/j.vaccine.2015.05.037_bib0255","doi-asserted-by":"crossref","first-page":"6151","DOI":"10.1016\/j.vaccine.2008.08.056","article-title":"Effect of pre-existing anti-tick-borne encephalitis virus immunity on neutralising antibody response to the Vero cell-derived, inactivated Japanese encephalitis virus vaccine candidate IC51","volume":"26","author":"Schuller","year":"2008","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2015.05.037_bib0260","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.vaccine.2012.12.075","article-title":"Factors associated with seroimmunity against tick borne encephalitis virus 10 years after booster vaccination","volume":"31","author":"Paulke-Korinek","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2015.05.037_bib0265","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vaccine.2008.10.045","article-title":"Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after hepatitis A re-vaccination in high and low-responder vaccinees","volume":"27","author":"Garner-Spitzer","year":"2009","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2015.05.037_bib0270","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.4049\/jimmunol.1300293","article-title":"Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10","volume":"191","author":"Garner-Spitzer","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.05.037_bib0275","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","article-title":"Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines","volume":"78","author":"Zuckerman","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2015.05.037_bib0280","first-page":"106","article-title":"Non-responders to hepatitis B vaccination: a review","volume":"6","author":"Kubba","year":"2003","journal-title":"Commun Dis Public Health"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15006891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T23:04:52Z","timestamp":1668639892000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15006891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":28,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0264410X15006891"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.037","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of antibodies six years after booster vaccination with inactivated vaccine against Japanese encephalitis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.05.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}